MicrobiologybioRxiv
Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria
K. Kiga, X.-E. Tan, R. Ibarra-Chavez…·L. Cui
This study develops CRISPR-Cas13a-based antimicrobials that kill target bacteria by cleaving RNA, showing effectiveness against carbapenem-resistant E. coli and methicillin-resistant S. aureus.
DOI 10.1038/s41467-020-16731-6